<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="under transmission electron microscope. Pro-inflammatory cytokine expression levels upon SARS-CoV-2" exact="infection" post="in Huh-7 cells were measured by real-time quantitative PCR"/>
 <result pre="CCL-2/MCP-1 and CXCL-10/IP-10) production at the mRNA levels. Furthermore, LH" exact="treatment" post="resulted in abnormal particle morphology of virion in cells."/>
 <result pre="increase is predictable. The initial patient cluster with confirmed SARS-CoV-2" exact="infection" post="was reported Wuhan pneumonia with unknown aetiology, which bore"/>
 <result pre="single-center case series of 138 hospitalized patients [8], and the" exact="infection" post="fatality risk could be below 1% or even below"/>
 <result pre="with the information available so far. Since no specific antiviral" exact="treatment" post="for COVID-19 is currently available, supportive cares, including symptomatic"/>
 <result pre="is remdesivir that is currently under clinical development for the" exact="treatment" post="of Ebola virus infection [11]. However, the efficacy and"/>
 <result pre="currently under clinical development for the treatment of Ebola virus" exact="infection" post="[11]. However, the efficacy and safety of remdesivir for"/>
 <result pre="by further clinical trials. In addition, in the prevention and" exact="treatment" post="of COVID-19, Tranditonal Chinese medicines have received broad adoption,"/>
 <result pre="of 13 herbs, has played a positive role in the" exact="treatment" post="of SARS-CoV-2. A retrospective analysis of clinical records was"/>
 <result pre="well as National Administration of Traditional Chinese Medicine for the" exact="treatment" post="of COVID-19. Moreover, LH exerted broad-spectrum effects on a"/>
 <result pre="effectiveness with Oseltamivir in reducing the course of H1N1 virus" exact="infection" post="[1,14,15]. Notably, the anti-influenza activity of LH in infected"/>
 <result pre="cytopathic effect by use of Reed-Muench method [17]. All the" exact="infection" post="experiments were performed in a biosafety level-3 (BLS-3) laboratory."/>
 <result pre="and then the plaques were counted and photographed. 2.6 RNA" exact="isolation" post="and reverse transcriptase-quantitative PCR analysis (RT-qPCR) The Huh-7 cell"/>
 <result pre="PBS and then exposed to coronavirus at a multiplicity of" exact="infection" post="(MOI) of 1 for 2 h at 37 °C."/>
 <result pre="with 5% CO2. The cells were then harvested for RNA" exact="isolation" post="and qPCR as described previously [16]. The primer and"/>
 <result pre="SARS-CoV-2 in vitro The cell viability after LH or remdesivir" exact="treatment" post="was determined by MTT assay in both Vero E6"/>
 <result pre="value of 411.2 μg/mL by CPE assay (Fig. 2A). Meanwhile," exact="treatment" post="with LH following infection also had a dose-dependent inhibitory"/>
 <result pre="by CPE assay (Fig. 2A). Meanwhile, treatment with LH following" exact="infection" post="also had a dose-dependent inhibitory effect on plaque formation"/>
 <result pre="G). LH (600 μg/mL) and positive control remdesivir (5 μM)" exact="treatment" post="resulted in a reduction of the number of virions"/>
 <result pre="expressions of these four cytokines were significantly inhibited by LH" exact="treatment" post="in a concentration-dependent manner (Fig. 4 ). Fig. 4"/>
 <result pre="concentration-dependent manner (Fig. 4 ). Fig. 4 Effects of LH" exact="treatment" post="on the mRNA expression levels of inflammatory mediators in"/>
 <result pre="respiratory diseases, LH is the only approved medicine in the" exact="treatment" post="of SARS and influenza. After the outbreak of SARS-CoV-2,"/>
 <result pre="virus replication and immunological regulation as it did on the" exact="infection" post="caused by influenza viruses. Our previous study showed that"/>
 <result pre="plasma vesicles in the SARS-CoV-2 infected cells, decreased in the" exact="treatment" post="of LH at 600ug/mL. Notably, slight deformation of virus"/>
 <result pre="Chinese medicine for COVID-19 treatmentPharmacol. Res.202010474332145402 13YaoK.Retrospective clinical analysis on" exact="treatment" post="of novel coronavirus-infected pneumonia with traditional chinese medicine Lianhua"/>
 <result pre="chinese medicine Lianhua QingwenChin. J. Exp. Trad. Med. Formulae202017 14LuH.Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV)Biosci. Trends1412020697131996494 15DuanZ.P.Natural herbal"/>
</results>
